Eric H. Yecies, Partner, Holland & Knight to Speak at TKG’s Hatch-Waxman Litigation Webinar

Eric H. Yecies with Holland & Knight will speak at TKG’s Hatch-Waxman Litigation:The Evolving Legal and Regulatory Framework on September 26, 2017 at 12:00pm ET

Online PR News – 08-September-2017 – New York – The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Eric H. Yecies, Partner, Holland & Knight will speak at the Knowledge Group’s webcast entitled: “Hatch-Waxman Litigation: The Evolving Legal and Regulatory Framework.” This event is scheduled for September 26, 2017 from 12:00pm – 2:00pm (ET).

For further details, please visit:

About Eric H. Yecies
Eric H. Yecies is an attorney in Holland & Knight’s New York office, serving as a partner in the firm’s Intellectual Property Group and sitting on the Hiring Committee. Mr. Yecies’ practice focuses on intellectual property, with an emphasis on litigating and counseling in the pharmaceutical, chemical, biotechnology and medical device areas. He has first chair trial experience in federal district courts and an active, complex appellate litigation practice before the U.S. Courts of Appeals.

Mr. Yecies litigates patent, design patent, trade secret, trademark, false advertising, anti-competitive, counterfeiting and licensing cases across technical disciplines, including controlled-release pharmaceuticals, fixed-dose combinations, nanoparticles, immuno-therapies, endocrine and hormone products, transdermal delivery, genetic engineering, oncogenetics, medical diagnostic agents, consumer products, crop science, and oncologic and neurologic treatments. He counsels on patent validity and infringement, licenses, commercial collaboration, patent prosecution, corporate due diligence and regulatory disputes.

About Holland & Knight
Holland & Knight is a global law firm with more than 1,250 lawyers and other professionals in 27 offices throughout the world. Among the nation's largest law firms, Holland & Knight provides representation in litigation, business, real estate and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.

To address your needs as effectively and efficiently as possible, we work collaboratively, drawing upon our depth and breadth of legal experience and industry knowledge. Our "one firm" structure positions us to support the most complex matters at all levels, with comprehensive and value-added service.

The firm is organized into four practice sections – Litigation, Government, Business and Real Estate. Through integrated practice groups and industry-based teams, we can provide efficient and responsive legal representation anywhere in the world. (

Event Synopsis:
Congress enacted the Hatch-Waxman Act, formally known as the Drug Price Competition and Patent Term Restoration Act of 1984, P.L. 98-417, to expedite and streamline both generic drug approvals and patent litigation relating to generic drugs. Prior to the adoption of the Act, no streamlined Food and Drug Administration (FDA) approval process existed for generic drugs. Instead, companies seeking to market generic drugs were required to conduct the same kinds of expensive, lengthy clinical trials that drug companies conducted for new brand-named drugs. Additionally, the Act provided a safe harbor to allow generic drug companies to investigate and patent new drugs in order to get FDA approval without the risk of patent infringement liability. See Roche Prods., Inc. v. Bolar Pharm. Co., 733 F.2d 858 (Fed. Cir. 1984).

Although the Hatch-Waxman Act has been amended multiple times since its enactment, the underlying structure remains the same, and the number of generic drugs successfully reaching the market has increased dramatically. However, along with the remarkable upsurge in approvals, the ever-changing landscape of Hatch-Waxman litigation creates new risks and challenges for both brand drug sponsor companies and generic companies every day.

Join a panel of key thought leaders and professionals assembled by The Knowledge Group in a LIVE Webcast as they bring the audience to a road beyond the basics of bringing or defending against Hatch-Waxman Litigation and as they delve into the in-depth analysis of the current trends and recent court rulings surrounding this significant topic. Speakers will also provide the audience with practical strategies in bringing out the best in these lawsuits in a rapidly evolving legal climate.

Key topics include:
• Hatch-Waxman Act: Fundamentals
• Litigation Trends and Pitfalls
• Recent Court Decisions
• Scope, Privileges and Limitations
• Trends, Developments and What Lies Ahead in 2018

About The Knowledge Group/The Knowledge Congress Live Webcast Series

The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: